Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using KRT20 mAb against human KRT20 (AA: 1-150) recombinant protein. (Expected MW is 42.8 kDa)Application
Figure 3:Western blot analysis using KRT20 mAb against HEK293 (1) and KRT20 (AA: 1-150)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Immunohistochemical analysis of paraffin-embedded colon cancer tissues using KRT20 mouse mAb with DAB staining.| Product Name | KRT20 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | K20; CD20; CK20; CK-20; KRT21 |
| Immunogen | Purified recombinant fragment of human KRT20 (AA: 1-150) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | K20 CD20 CK20 CK-20 KRT21 |
|---|---|
| Molecular Weight(MW) | 48.5kDa |
| Entrez Gene | 54474 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using KRT20 mAb against human KRT20 (AA: 1-150) recombinant protein. (Expected MW is 42.8 kDa)
Application
Figure 3:Western blot analysis using KRT20 mAb against HEK293 (1) and KRT20 (AA: 1-150)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Immunohistochemical analysis of paraffin-embedded colon cancer tissues using KRT20 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
